Medical Device Quality Systems: FDA QMSR, ISO 13485 and Device Pathways

Independent · source-linked · manufacturing-first

As of February 2, 2026, FDA's Quality Management System Regulation is effective. It incorporates ISO 13485:2016 by reference and changes the framework medical-device manufacturers use to demonstrate quality-system compliance in the United States.

QMSR is now the current framework

FDA states that the QMSR became effective on February 2, 2026 and amended 21 CFR Part 820 by incorporating ISO 13485:2016. Finished-device manufacturers should use FDA's current text and inspection resources, not an undated summary of the former QS Regulation.

Classification comes before submission strategy

FDA groups device types into classes according to the controls needed for safety and effectiveness. The device type, intended use, product code and available predicate landscape help determine whether the route is exemption, 510(k), De Novo or PMA.

A certificate is not the whole system

An ISO 13485 certificate can be relevant to supplier qualification, but the scope, site, activities and issuing body matter. Device manufacturers remain responsible for their approved suppliers, specifications, records and regulatory obligations.

Use authoritative tools

FDA's classification, 510(k), PMA, De Novo, registration/listing, recall and UDI databases answer different questions. Search the correct system, confirm the current record and preserve the date of your review.

Continue the medical manufacturing map

Independent educational reference: Machine Blue Book is not affiliated with Arthrex, FDA, ISO or any manufacturer named on this page. Names are used descriptively and linked to primary sources. This material is not medical, legal, regulatory or clinical advice and does not recommend a device for patient care.